← All candidates
Six insider buys in the last year — $125.7K in all.
6 filings on record.
ACONAclarion, Inc.
NasdaqCM · Healthcare · $7.55M
$2.62
+1.55% · Sep 15
Six insider buys in the last year — $125.7K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 6 buys◆ 5 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 3×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ACON ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$7.55M
Float
2.5M
87% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
90.2
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Bond Ryan
Bought $50.1K on Aug 13 — 21,122 sh @ $2.37, held direct, 28% of their stake.
First Form 4 on file
CFO
Gould Gregory A
Bought $24.5K on Aug 14 — 10,000 sh @ $2.45, held direct, 17% of their stake.
First Form 4 on file
Director
Neal David K
Bought $18.0K on Aug 13 — 7,500 sh @ $2.40, held direct, 25% of their stake.
First Form 4 on file
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
1 more transaction on Pro →Context
Wall St
$7.50 avg target
+186.3% vs today · 1 analyst
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q2 '26−$1.12 act−$0.07
Q1 '26−$1.34 act+$0.21
Q4 '25−$4.52 act−$0.92
Q3 '25−$2.93 act−$0.29
The file stays open
6 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice